Intermacs participation is available to all North American hospitals that implant durable mechanical circulatory support devices (MCSD) for end-stage heart failure. An annual participation fee is required. In return, each participating site receives quarterly site-specific reports comparing their data with data from other participating centers.


  • Provide Intermacs with annual renewal documents prior to the due date.
  • Remember to have the subject date the informed consent at the time of signature.
  • All subjects that transfer from one Intermacs site to another must complete a new Informed Consent and a Patient Authorization for Intermacs to Release Information form.
  • Transmit correspondence with Protected Health Information (PHI) only through a secure e-mail process.